June 1-5, 2018

Abstract Submission Guidelines

Overall Scientific Theme and Programme

Strengthening the Evidence-to-Action Connection

With terms such as “fake news”, “alternative facts”, and “post-truth” now in common parlance, it is more important than ever that researchers, policymakers, health care practitioners, technology developers, patients, and the public affirm their commitment to action based on evidence and collaborative approaches that will strengthen the evidence-to-action connection. The HTAI 2018 Annual meeting will provide an unparalleled opportunity to consider, debate and clarify the role of health technology assessment (HTA) in the health care ecosystem.

With three plenary sessions that all support the conference’s overarching theme of Strengthening the Evidence-to-Action Connection, the HTAi 2018 Annual Meeting will be a must-attend event for those in the global HTA community to consider and debate:

As the leading global discussion platform for all stakeholders engaged in the efficient production and use of HTAs in decision-making, HTAi supports and promotes the development, communication, understanding and use of HTA around the world as a scientifically-based and interdisciplinary means of informing decision making on the use of effective technologies and the efficient use of resources in health care. HTAi welcomes all stakeholders – patients/consumers, health care providers, academic researchers, HTA agencies, payers, policy makers, industry – to join us.

Three plenary sessions will be led by experts in their respective fields and will cover the following topics

The Annual Meeting in Vancouver will provide an opportunity to consider the following themes and topics in workshops, panels, oral presentations, vignettes and posters:

  1. Methods in HTA
    1. Research on HTA methods, including novel methods for conducting HTA (e.g. rapid reviews, adapting existing HTAs)
    2. Horizon scanning
    3. Information retrieval
    4. Evidence quality including bias, transferability and generalisability
    5. Clinical effectiveness
    6. Safety
    7. Costs and economic evaluation
    8. Ethical, social and legal aspects of HTA
    9. Big data analysis and use of Real World Data for HTA
    10. Precision and personalised medicine and companion diagnostics
  2. Policy issues in HTA
    1. Regulatory-HTA alignment
    2. Value-based health policy and value frameworks
    3. Reassessment and disinvestment
    4. Capacity building in HTA, enhancing skills and capabilities at country level
    5. Country-specific HTA
    6. Regional HTA Networks
    7. Comparative HTA systems
  3. Hospital-based HTA
    1. HTA and procurement
    2. HTA and health technology management
  4. HTA and Clinical Practice Guidelines
  5. Stakeholder involvement in HTA
    1. Patient involvement
    2. Public involvement
    3. HTA and shared decision-making
    4. Engagement of health care professionals
    5. HTA in the media and including specialist and general media and social media
    6. Other (including academic and payers)
  6. HTA – presenting results of HTAs
    1. Pharmaceuticals
    2. Medical devices
    3. Vaccines
    4. Tests (predictive or diagnostic, including personalised/precision medicine)
    5. Procedures & other interventions (e.g., surgery, screening programmes)
    6. Social services
    7. eHealth and mHealth
    8. Other
  7. Other topics

Abstract Submissions

When submitting abstracts applicants will be asked to select from the above list of topics to identify the one that most closely matches the theme of their abstract. Reviewers will identify their area of expertise on the basis of this same list of topics. This ensures that all abstracts are assessed by knowledgeable reviewers.

HTAi will also look to ensure there is a strong presence at the conference of students and presenters from low and middle-income countries (LMICs).

1) Panel and Workshop Submissions

2) Oral, Vignette and Poster Submissions

General Information

  1. Submission deadlines are different based on submission type. Please note below important dates regarding abstract submissions.  No extensions to these deadlines will be made.
    Open Call for Abstracts: Mid-September, 2017
    Deadline for Workshop & Panel submissions: October 16, 2017
    Deadline for Oral, Vignette & Poster Presentation submissions: November 24, 2017Receipt of abstract submission will be acknowledged via e-mail prior to submission close for each category.
  2. Submission details
    1. General submission details:
      • All proposals must be submitted via the online abstract submission system. HTAi will accept proposals by email from people who have conditions that prevent them using the online submission system.
      • Abstract submissions must include a brief description (less than 60 words) that would allow delegates to assess relevance and interest to them. Descriptions will be displayed on the Annual Meeting website and mobile app, in the programme and the abstract book.
      • Submitters may return to the online abstract submission system to edit their abstracts, add or delete authors, moderators or presenters, revise information, or withdraw abstracts at any time before the submission deadline.
      • Accepted abstracts will be published in the Annual Meeting materials (e.g. website, mobile app, programme and abstract book) as submitted. Changes to abstracts will not be accepted after the Submission Deadline.
      • If authors wish their abstracts to go into the Supplement of International Journal of Technology Assessment in Health Care (IJTAHC) then a fully completed copyright form must accompany the submission. Link to the Copyright Assignment Form. The abstracts that will be published in the Supplementary Issue of International Journal of Technology Assessment in Health Care might be subject to further review and authors might be contacted for revisions.
      • Abstract submissions and presentations must be in English.
      • Abstract submissions must not include references. However, the ISPC strongly encourages presenters to include all appropriate citations in their presentation at the Annual Meeting.
      • Abstract submissions must not include tables, figures  and charts.
      • Please spell out all acronyms on first use.
      • Abstract submissions and presentations must not promote any product or service.
      • Abstract submission and presentation expenses are the responsibility of the abstract submitter (primary contact) and presenter. For presenters requiring financial support to attend the Annual Meeting, HTAi offers a limited number of Travel Grants each year (subject to conditions and availability).
      • The presenters of research are required to declare sources of funding for their presented work.
      • Local Organising Committee members, HTAi partner organisations and interest group chairs should contact the ISPC Co-Chairs with their relevant abstract submission numbers to inform them about their official submissions.
    2. Workshop and Panel submission details:
      • For workshops and panels, the abstract text must not exceed 500 words. Word count will include: introduction, structure of the session, objectives and outcomes. For workshops, you will need to specify target audience and method of interactive activities.
      • The title must not exceed 100 characters and must accurately reflect content.
      • Please make sure your abstract title fits within the allotted space and is written in title case (i.e.: An Introduction To Health Technology Assessment).
      • Title, chairs and presenters as well as affiliated institutes are not included in the word count.
      • For a panel of 75 minutes, please limit your presenters to a maximum of 5
    3. Oral, Vignette and Poster submission details:
      • For oral, vignette and poster presentations, the abstract text must not exceed 300 words. Word count will include: introduction, methods, results and conclusions
      • Title, authors and affiliated institutes are not included in the word count.
      • Title must not exceed 70 characters and must accurately reflect content
      • Please make sure your abstract title fits within the allotted space and is written in title case (i.e.: An Introduction To Health Technology Assessment).
  3. Review, Acceptance, Notification and final inclusion in the official Programme
    1. Review: All abstracts will be peer reviewed by three experts identified by the HTAi International Scientific Programme Committee (ISPC). Panel and workshop submissions will be reviewed by members of the ISPC. Oral, vignette and poster submissions will be reviewed by a broad group of reviewers, coordinated by the HTAi Secretariat, which will include ISPC members and a selected group of experts in the HTA field. Final decisions about inclusion and organisation of the programme will be made by the ISPC, led by the ISPC Co-Chairs.
    2. Abstract Acceptance & Notifications:
      • Workshops and Panels: After review, the abstract’s primary contact will receive an email notification indicating the abstracts acceptance or rejection by November 17, 2017. Registration for the Annual Meeting must be submitted by March 31, 2018 (early bird registration deadline), to ensure inclusion in the Annual Meeting programme.
      • Oral, Vignette and Poster Presentations: After review, the abstract’s primary contact will receive an email notification indicating the abstract’s acceptance or rejection by January 26, 2018. Registration for the Annual Meeting must be submitted by March 31, 2018 (early bird registration deadline), to ensure inclusion in the Annual Meeting programme.
    3. Final inclusion in the official Annual Meeting Programme:
      • Workshops and Panels: Until the Early Bird Deadline (31 March 2018), at least one of the named chairs/moderators must be registered for the Annual Meeting to confirm the final inclusion in the official Annual Meeting Programme. Panels and Workshops which do not fulfil this requirement will be withdrawn from the programme.
      • Oral, Vignette and Poster Presentations: Until the Early Bird Deadline (31 March 2018), the abstract’s primary presenter must be registered for the Annual Meeting to confirm the final inclusion in the official Annual Meeting Programme. Oral, Vignette and Poster Presentations which do not fulfil this requirement will be withdrawn from the programme.
  4. Publication of abstract content
    1. Annual Meeting Materials:
      • Submission of abstracts constitutes all authors’ consent to have their abstracts published on the HTAi 2018 website, mobile app, within the programme and abstract book.
      • Please review your abstract prior to submission, check grammar and spelling and ensure all special characters and formatting display correctly. Accepted abstracts will be published in the Annual Meeting Materials (e.g. website, mobile app, programme and abstract book) as submitted. Changes to abstracts will not be accepted after the Submission Deadline.
    2. Supplementary Issue of the International Journal of Technology Assessment in Health Care: Accepted abstracts of oral, vignette and poster presentations have the possibility to be published in a Supplementary Issue of the International Journal of Technology Assessment in Health Care. Abstract submitters will be able to provide their consent for publication in the abstract submission form. Once abstracts have been accepted for the official programme, there will be an editing process and if any major changes are recommended these will be communicated to the abstract submitter (primary contact). If authors would like to have their abstracts to go into the Supplement of IJTAHC then a fully completed copyright form must accompany the submission. Link to the Copyright Assignment Form. The Supplementary Issue will be published ahead of the meeting.

 

Scoring Criteria

The scoring system applied to all abstracts will take into consideration gender balance, the involvement of students, and contributions from people from low and middle-income countries (LMIC) as well as patients, users and clients.

  1. Appropriateness to HTAi
    The concept of the abstract should be appropriate to HTAi, and in alignment with the main themes of the Annual Meeting. Panels and workshops should have presenters who are knowledgeable about the subject matter, and collectively, represent a variety of different perspectives and/or settings.
  2. Original and Innovative Contribution
    Abstracts with original and innovative ideas will receive a higher score. In particular:

    • Challenging existing paradigms or HTA practice
    • Addressing an innovative hypothesis or critical barriers/issues to progress
    • Developing or enhancing novel concepts, approaches or methodologies, tools, or technologies for this area.
  3. Abstract Structure & Quality
    • Workshop and panel abstracts must have the following structure:
      Title: must not exceed 100 characters, with no abbreviations and the beginning of each word is capitalized
      Introduction: Include the scientific background and rationale for the panel or workshop, and a clear statement of the issue. Must be clearly stated to achieve the highest score.
      Structure of the session: Give the structure of your workshop/panel (e.g. presenters, timing, format of interaction, etc.) and your plans to generate a vibrant discussion or learning environment.
      Panel/Workshop outcome and objectives: Explain what you would like to accomplish during your workshop/panel session, the sessions contribution to HTA capacity building as well as the benefits and takeaways for the audience or participants.
      Moderators/Presenters: Include name, organization, position of all presenters and speakers, as well as the title (or brief description) of their specific contribution. Only confirmed moderators/speakers can be submitted with your application.
      Declaration of funding: Please declare sources of funding of the research
      Basic quality: Workshops and panel abstracts should be appropriately summarised, and grammar and spelling should be checked
    • Oral, vignette and poster abstracts must have the following structure:
      Title: must not exceed 70 characters, with no abbreviations and the beginning of each word is capitalized
      Introduction: Include the scientific background and rationale, and give a clear statement of the problem, issue, study goal, objectives, and/or research hypothesis. Must be clearly stated to achieve the highest score.
      Methods: For quantitative and related studies, include a clear statement of perspective, data collected, sources of data, analyses including statistical testing, etc. Clearly describe the populations studied, method of accrual and sample frame and analytical techniques. For conceptual, institutional, organisational, or policy papers, provide a concise description of the content of the paper or report to be presented, and other relevant factors such as policy analysis of alternatives, details of qualitative methods, etc.
      Results: Present the most important study findings, including generalisability to other populations, health systems or countries if relevant. Abstracts must reflect work that has already been done (i.e. results available) or at least provide preliminary results suggesting that the work is in progress and that results will be available to present at the annual meeting.
      Conclusions: Provide a concise statement on the most important findings or policy implications.  You should also address the question, “What do these results mean for your main area of research?” If relevant, include next steps, proposals for further research and study limitations.
      Declaration of funding: Please declare sources of funding of the research
      Basic quality: Oral, poster and vignette abstracts should be appropriately summarised, and grammar and spelling should be checked.

Style Guidelines

Please consider the following style guidelines as a general direction in the submission process to have the abstracts submitted as consistent and standardised for Annual Meeting publications (website, mobile app, programme and abstract book). These guidelines are in line with those required for abstracts to be included in the Supplementary Issue of the International Journal of Technology Assessment in Health Care.